Jennifer L. McNeer to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications Jennifer L. McNeer has written about Antineoplastic Combined Chemotherapy Protocols.
Connection Strength
0.486
-
Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children. N Engl J Med. 2025 Feb 27; 392(9):875-891.
Score: 0.107
-
Improving infectious adverse event reporting for children and adolescents enrolled in clinical trials for acute lymphoblastic leukemia: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2022 11; 69(11):e29937.
Score: 0.092
-
Management of CNS Disease in Pediatric Acute Lymphoblastic Leukemia. Curr Hematol Malig Rep. 2022 02; 17(1):1-14.
Score: 0.088
-
Levocarnitine for asparaginase-induced hepatic injury: a multi-institutional case series and review of the literature. Leuk Lymphoma. 2018 10; 59(10):2360-2368.
Score: 0.067
-
Outcomes in adolescents and young adults with Hodgkin lymphoma treated on US cooperative group protocols: An adult intergroup (E2496) and Children's Oncology Group (COG AHOD0031) comparative analysis. Cancer. 2018 01 01; 124(1):136-144.
Score: 0.065
-
Pediatric Acute Lymphoblastic Leukemia: From Diagnosis to Prognosis. Pediatr Ann. 2015 Jul; 44(7):e168-74.
Score: 0.056
-
Beyond the 2008 World Health Organization classification: the role of the hematopathology laboratory in the diagnosis and management of acute lymphoblastic leukemia. Semin Diagn Pathol. 2012 Feb; 29(1):2-11.
Score: 0.011